Raloxifene may infrequently cause serious blood clots to form in the legs or lungs. Tell your doctor if you have history of blood clots (e.g., deep venous thrombosis, pulmonary embolism). Also talk to your doctor about risk factors for developing strokes (sometimes fatal) while taking this medication. Some risk factors include tobacco use, alcohol use, having high cholesterol/diabetes, or history of heart disease. Discuss...
Read moreFor the past few years, most physicians have routinely treated osteoporosis in the same manner. The most commonly used medication class is... Read more »
Preventing deaths. Tamoxifen has long been hailed as a wonder drug for preventing recurrences of breast cancer. In the 1990s, studies... Read more »
For years, women who were at high-risk for developing invasive breast cancer, or already had the disease and were trying to prevent a... Read more »
Q. My family history of breast cancer (both my mother and sister have had it) puts me at high risk of the disease. And now that I'm pushing... Read more »
Isn't it ironic? Just a couple of years after paying a fine for the illegal promotion of Evista as a breast cancer prevention drug,... Read more »
Source: Breastcancer.org
Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: reduce the risk of... Read more »
Source: Breastcancer.org
Chemical name: Evista Brand name: Raloxifene Class: SERM (selective estrogen receptor modulator) hormonal therapy. Tamoxifen and Fareston are other... Read more »
A new study has found that the osteoporosis drug Evista (raloxifene) was effective at treating postmenopausal women with schizophrenia. Researchers... Read more »
Source: Breastcancer.org
LCIS does not require treatment in the way you might normally think of cancer treatment, such as needing to have surgery, radiation therapy, and... Read more »
Source: Harvard Decision Guide
Prevention You can help to prevent osteoporosis by: Getting enough calcium and vitamin D - Many doctors routinely recommend extra... Read more »